Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab (vol 115, pg 71, 2018)

被引：3
|
作者：
Sato, Koichi [1 ]
Akamatsu, Hiroaki [1 ]
Murakami, Eriko [1 ]
Sasaki, Seigo [1 ]
Kanai, Kuninobu [1 ]
Hayata, Atsushi [1 ]
Tokudome, Nahomi [1 ]
Akamatsu, Keiichiro [1 ]
Koh, Yasuhiro [1 ]
Ueda, Hiroki [1 ]
Nakanishi, Masanori [1 ]
Yamamoto, Nobuyuki [1 ]
机构：
[1] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan
来源：
LUNG CANCER | 2018年 / 126卷
关键词：
D O I：
10.1016/j.lungcan.2018.11.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [11] Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
    Burke, Michael
    Rashdan, Sawsan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [12] Immune-related adverse events to predict survival in patients with advanced non-small cell lung cancer treated with nivolumab: A multicenter analysis.
    Ricciuti, Biagio
    De Giglio, Andrea
    Brambilla, Marta
    Bassanelli, Maria
    Metro, Giulio
    Ludovini, Vienna
    Baglivo, Sara
    Chiari, Rita
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [13] Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer
    Noguchi, Susumu
    Suminaga, Keiichiro
    Kaki, Takahiro
    Kawachi, Hiroaki
    Fukao, Akari
    Terashita, Satoshi
    Horikawa, Sadao
    Ikeue, Tatsuyoshi
    Sugita, Takakazu
    LUNG CANCER-TARGETS AND THERAPY, 2020, 11 : 53 - 57
  • [14] Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
    Masuda, Ken
    Shoji, Hirokazu
    Nagashima, Kengo
    Yamamoto, Shun
    Ishikawa, Masashi
    Imazeki, Hiroshi
    Aoki, Masahiko
    Miyamoto, Takahiro
    Hirano, Hidekazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Boku, Narikazu
    BMC CANCER, 2019, 19 (01)
  • [15] Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
    Ken Masuda
    Hirokazu Shoji
    Kengo Nagashima
    Shun Yamamoto
    Masashi Ishikawa
    Hiroshi Imazeki
    Masahiko Aoki
    Takahiro Miyamoto
    Hidekazu Hirano
    Yoshitaka Honma
    Satoru Iwasa
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Narikazu Boku
    BMC Cancer, 19
  • [16] PREDICTIVE BIOMARKERS OF SEVERE IMMUNE-RELATED ADVERSE EVENTS IN NON-SMALL CELL LUNG CANCER
    Magalhaes Ferreira, P.
    Serino, M.
    Freitas, C.
    Martins, M.
    Cardoso, C.
    Sousa, C.
    Santos, V.
    Araujo, D.
    Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    CHEST, 2022, 161 (06) : 311A - 311A
  • [17] Singular immune-related adverse events and efficacy outcomes of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Garcia, J. M. Jurado
    Dols, M. Cobo
    Cantero, A.
    Calderon, V. Gutierrez
    Gallego, P. Jimenez
    Ruiz, E. Perez
    Guerrero, M. A. Berciano
    Pino, A. Montesa
    Garcia, I. Ramos
    Dominguez, A. Rueda
    ANNALS OF ONCOLOGY, 2023, 34
  • [18] Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study
    Teraoka, Shunsuke
    Fujimoto, Daichi
    Morimoto, Takeshi
    Kawachi, Hayato
    Ito, Munehiro
    Sato, Yuki
    Nagata, Kazuma
    Nakagawa, Atsushi
    Otsuka, Kojiro
    Uehara, Keiichiro
    Imai, Yukihiro
    Ishida, Kaori
    Fukuoka, Junya
    Tomii, Keisuke
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (12) : 1798 - 1805
  • [19] Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study
    Kana Kurokawa
    Yoichiro Mitsuishi
    Naoko Shimada
    Yuta Kawakami
    Keita Miura
    Taichi Miyawaki
    Tetsuhiko Asao
    Ryo Ko
    Takehito Shukuya
    Rina Shibayama
    Shuko Nojiri
    Kazuhisa Takahashi
    BMC Cancer, 22
  • [20] Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study
    Kurokawa, Kana
    Mitsuishi, Yoichiro
    Shimada, Naoko
    Kawakami, Yuta
    Miura, Keita
    Miyawaki, Taichi
    Asao, Tetsuhiko
    Ko, Ryo
    Shukuya, Takehito
    Shibayama, Rina
    Nojiri, Shuko
    Takahashi, Kazuhisa
    BMC CANCER, 2022, 22 (01)
12345